Elisabeth Kjellén
71 – 80 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
(
- Contribution to journal › Article
-
Mark
Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma.
(
- Contribution to journal › Article
-
Mark
Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays
(
- Contribution to journal › Article
- 2005
-
Mark
In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
(
- Contribution to journal › Article
- 2004
-
Mark
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
- 2003
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in non-small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
Research and development of radiation therapy in clinical routines
(
- Contribution to journal › Article
- 2002
-
Mark
FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Sensitizing and protective substances in radiation therapy and predictive assays
(
- Contribution to journal › Article